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We have performed genetic linkage analysis in 13 large multiply affected families, to test the hypothesis that there
is extensive heterogeneity of linkage for genetic subtypes of schizophrenia. Our strategy consisted of selecting 13
kindreds containing multiple affected cases in three or more generations, an absence of bipolar affective disorder,
and a single progenitor source of schizophrenia with unilineal transmission into the branch of the kindred sampled.
DNA samples from these families were genotyped with 365 microsatellite markers spaced at ∼10-cM intervals
across the whole genome. We observed LOD scores 13.0 at five distinct loci, either in the sample as a whole or
within single families, strongly suggesting etiological heterogeneity. Heterogeneity LOD scores 13.0 in the sample
as a whole were found at 1q33.2 (LOD score 3.2; ), 5q33.2 (LOD score 3.6; ), 8p22.1-22Pp .0003 Pp .0001
(LOD score 3.6; ), and 11q21 (LOD score 3.1; ). LOD scores 13.0 within single pedigreesPp .0001 Pp .0004
were found at 4q13-31 (LOD score 3.2; ) and at 11q23.3-24 (LOD score 3.2; ). A LOD scorePp .0003 Pp .0003
of 2.9 was also found at 20q12.1-11.23 within in a single family. The fact that other studies have also detected
LOD scores 13.0 at 1q33.2, 5q33.2, 8p21-22 and 11q21 suggests that these regions do indeed harbor schizophrenia-
susceptibility loci. We believe that the weight of evidence for linkage to the chromosome 1q22, 5q33.2, and 8p21-
22 loci is now sufficient to justify intensive investigation of these regions by methods based on linkage disequilibrium.
Such studies will soon allow the identification of mutations having a direct effect on susceptibility to schizophrenia.
Introduction
Although it is clear that genetic factors have a substantial
effect on the risk of development of schizophrenia (Gur-
ling 1996), attempts to use genetic analysis in the de-
termination of a mode of transmission have produced
conflicting results (Baron 1986; Risch 1990; Gurling
1996; Pritchard 1996). The high prevalence (.085) of
schizophrenia (MIM 181500) in the population makes
it certain that heterogeneous factors contribute to the
etiology, and, if genetic risk factors differ in their nature
and magnitude in different individuals, then such anal-
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yses will not produce valid results. It is highly likely that
genetic effects within a single family are more homo-
geneous than are those between families. Recent work
supports the view that, unless a polymorphism is very
common and has only a minor effect on risk, extended
pedigrees have more power for detection of linkage than
do smaller structures such as sib pairs (Durner et al.
1999). With these considerations in mind, we chose to
study large, densely affected families that appeared to
demonstrate only a single source of schizophrenia and
that also appeared to demonstrate subsequent unilineal
inheritance.
Previous Linkage Studies of Schizophrenia
Previous linkage studies have been reviewed and sum-
marized in the workshop reports of the 5th Internation-
al and 6th World Congresses of Psychiatric Genetics
(Nurnberger and Gurling 1998; Tsuang 1999). Ten re-
ports of studies in which the whole genomewas screened
for schizophrenia-susceptibility genes have now been
published (Coon et al. 1994; Moises et al. 1995; Straub
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et al. 1997a; Blouin et al. 1998; Faraone et al. 1998;
Levinson et al. 1998; Hovatta et al. 1999; Williams et
al. 1999; Paunio et al. 2000). Many other studies have
tested for linkage over small genetic distances on many
chromosomes, and these are mentioned below in the
discussion of our own linkage analyses.
Chromosome 1q
The presence of a susceptibility locus on chromosome
1q (SCZD9 [MIM 604906]) is supported by linkage
analysis and by the association of schizophrenia with
cytogenetic abnormalities (St. Clair et al. 1990; Kosower
et al. 1995; Ekelund et al. 1997; Blackwood 1998; Hov-
atta et al. 1999; Brzustowicz et al. 2000; Millar et al.
2000). One large Scottish kindred has demonstrated sig-
nificant linkage between schizophrenia and related dis-
orders and a balanced translocation involving chro-
mosomes 1 and 11, t(1;11)(q42.1;q14.3) (St. Clair et al.
1990; Millar et al. 2000). The Finnish linkage study by
Hovatta et al. (1999) supported linkage between a highly
(90%) penetrant dominant locus with loci D1S2141 and
D1S2891, with two-point admixture LOD scores of 3.73
and 3.82, respectively. This position is slightly telomeric
to that implicated by Kosower et al. (1995), who pub-
lished a combined allelic association, cytogenetic, and
family study of heterochromatic C-band variants in the
q22.1-23 region of chromosome 1. In one family, they
observed cosegregation of a 1qH (C-band) variant and
the Duffy blood-group alleles with schizophrenia (Ko-
sower et al. 1995). The region identified by Hovatta et
al. (1999) appears to be slightly centromeric to the chro-
mosome 1q42.1 region implicated byMillar et al (2000).
The second genome scan of schizophrenia in Finland
(Ekelund et al. 1997), using a national sib-pair sample,
also provided some evidence of linkage to this region
on chromosome 1. However, the strongest support for
linkage on 1q22 derives from a schizophrenia-linkage
study using large, multiply affected Canadian families
(Brzustowicz et al. 2000). The maximum three-point
multipoint LOD score was 6.50 ( ) on 1q22,Pp .0002
between markers D1S1653 and D1S1679, with 75% of
families estimated to have schizophrenia linked to this
locus.
Chromosome 5p
In our initial genetic linkage analyses, in seven families
from Iceland and the United Kingdom, we found positive
LOD scores with linkage markers D5S39 and D5S76,
which were originally thought to be localized on chro-
mosome 5q11-13 (SCZD1 [MIM 181510]) (Sherrington
et al. 1988). Further analyses, with newly created genetic
linkage markers and a larger sample of 23 families (Sher-
rington et al. 1993), showed diminished support for link-
age over this region (Kalsi et al. 1999). The original
study, as well as replications performed at that time by
other research groups, used relatively uninformative
low-heterozygosity RFLPs to attempt replication; in ad-
dition, these markers were poorly localized. Since then,
D5S39 has been placed closer to the centromere, and
locus D5S76, which gave us the highest LOD score, has
been repositioned, on the short arm of chromosome 5,
at 5p14.1-13.1 (Buetow et al. 1994), between The Ge-
nome Database locations for D5S419 andD5S395 (Gya-
pay et al. 1994). A genome scan of schizophrenia by
Moises et al. (1995), who studied five Icelandic pedi-
grees, also screened chromosome 5p and obtained neg-
ative results. However, the selection criteria for ascer-
tainment of families were different from our own
criteria, and, indeed, the Icelandic study by Moises et
al. (1995) included two pedigrees that we had excluded
because they were bilineal and because they contained
multiple cases of schizophrenia and bipolar affective
disorder, in several generations. Silverman et al. (1996)
have reported a maximized two-point LOD score of 4.37
between schizophrenia and D5S111 in a single family,
with some evidence of linkage to D5S477, D5S651, and
D5S674, as well. All of these markers map to chro-
mosome 5p14.1-13.1 and, like D5S76, lie between
markers D5S419 and D5S395. One further study of the
5p14.1-13.1 region, by Garver et al. (1998), found non-
parametric LOD scores of 2.49 and 2.55 with the mark-
ers D5S111 and D5S426, respectively. These loci are
closely linked to D5S419. A further study of the 5p14.1-
13.1 region in Canadian families with schizophrenia
(King et al. 1997) failed to find any evidence for linkage,
as have several other genome scans of schizophrenia.
Chromosome 5q
A second region on chromosome 5 has been impli-
cated, in a set of Irish pedigrees (Straub et al. 1997b),
with heterogeneity LOD scores (HLODs) of 3.04
( ) and 3.35 ( ) at D5S393 andPp .0005 Pp .0002
D5S804, respectively. A collaborative study of 5q22-31
(Levinson 1999) found that four of eight independent
samples gave LOD scores 11.00. Some further degree of
support for the involvement of this locus was obtained
in a study of a sample of German families, which pro-
duced a LOD score of 1.8 at 5q22-31, with marker
D5S399 (Schwab et al. 1997). Subsequently, a study of
a single large kindred from Palau, Micronesia, gave a
LOD score of 3.4 for markers in the 5q22-31 region
(Byerley et al. 1999). Finally, a linkage study of Finnish
families has also found schizophrenia linkage, with a
LOD score 13.00 at 5q22-31 (Paunio et al. 2000).
Chromosome 8p
The 8p22-21 region on chromosome 8 was originally
identified as showing possible genetic linkage to schizo-
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phrenia (SCZD6 [MIM 603013]), as part of a genome-
wide search, with a maximum admixture LOD score, at
D8S136, of 2.35, under a dominant model and 2.20
under a recessive model (Pulver et al. 1995). This result
was followed up, within the same family sample (Blouin
et al. 1998), with new markers, giving a LOD score of
3.64 ( ). Another study (Kendler et al. 1996)Pp .0001
obtained HLODs of 2.00 with D8S1731, 2.52 with
D8S1715, and 2.08 with D8S133. Elsewhere, we have
published the results obtained, through use of three
markers from this region, from 23 Icelandic and British
families (Kalsi et al 1996). Using the MFLINK linkage-
analysis program (Curtis and Sham 1995), we found a
maximized LOD score of 2.17 with marker D8S136.
Further analyses, using multipoint LOD scores and ad-
ditional markers, also supported linkage. The present
report describes the results from a subset of the 13 largest
families drawn from this sample of 23 pedigrees. In re-
sponse to the initial findings on chromosome 8, 14 re-
search groups genotyped 14 microsatellite markers in a
collaborative sample of 403–567 pedigrees (Levinson et
al. 1996), which included both the pedigrees originally
showing evidence of linkage as well as newly typed ped-
igrees. These yielded HLODs of 2.22 ( ) forPp .0014
the new sample and of 3.06 ( ) for the com-Pp .00018
bined sample. Recently, study of a Canadian sample has
provided further support for linkage to this region, with
a LOD score of 3.49 (Brzustowicz et al. 1999). Other
studies of 8p21-22 have either offered less-significant
statistical support or have been negative (Hovatta et al.
1999; Williams et al. 1999).
Chromosome 11q
As described above, a balanced t(1;11)(q42.1;q14.3)
translocation was found to cosegregate with schizo-
phrenia and other psychiatric disorders in a single large
Scottish pedigree (St. Clair et al. 1990; Blackwood et al.
1998; Millar et al. 2000). Analysis of linkage between
both the chromosome 1q and 11q translocations and
the disease locus produced LOD scores that varied be-
tween 3.1 and 6.0, according to the disease model ap-
plied. Marker D11S931 was found to lie very close to
the chromosome 11 translocation breakpoint that co-
segregates with both schizophrenia and other, nonpsy-
chotic, psychiatric disorders (Devon et al. 1997; Devon
and Porteous 1997). A number of linkage studies of this
region have been negative (Gill et al. 1993; Wang et al.
1993; Mulcrone et al. 1995). However a linkage study
of a Japanese population (Nanko et al. 1992) discovered
LOD scores of 1.00–1.50 with marker D11S35, and, in
a separate study, one of four Canadian pedigrees pro-
duced a LOD score of 3.41 with D11S35 (SCZD2 [MIM
603342]) (Maziade et al. 1995). Other linkage studies
have failed to detect any evidence of linkage on chro-
mosome 11 (Kalsi et al. 1995c; Moises et al. 1995;
Straub et al. 1997a; Faraone et al. 1998; Kaufmann et
al. 1998).
Subjects and Methods
Thirteen pedigrees containing individuals with schizo-
phrenia were investigated. These kindreds constituted
the most densely affected and largest of the 23 pedigrees
used in our previous linkage studies. They consisted of
five British and eight Icelandic families, as described else-
where (Kalsi et al. 1995b, 1996; Chen et al. 1997). They
were contributed to a large multicenter collaboration
organized by the European Science Foundation (ESF),
which arranged for the genotyping to be performed. Di-
agnoses were assigned through use of Research Diag-
nostic Criteria (RDC) (Spitzer et al. 1978). Subjects were
interviewed through use of the Lifetime Version of the
Schizophrenia and Affective Disorders Schedule SADS-
L (Spitzer and Endicott 1977). This information was
supplemented by material from case notes. Subjects were
also rated for schizoid personality and schizotypal dis-
order, through use of Diagnostic and Statistical Manual
of Mental Disorders (3d edition, revised) (DSM-IIIR)
criteria. Two psychiatrists who were blind to the ge-
notyping assigned consensus diagnoses. Extensive trac-
ing of pedigrees was done, and attempts were made to
characterize the diagnoses of other members of the kin-
dreds as accurately as possible. In total, 1,850 individ-
uals were entered into a database, with affection status
derived from case records, direct interviews, and diag-
nostic information. For those individuals who were not
interviewed, medical records were used to assign RDC
diagnoses. In some cases no medical records were avail-
able, but we had been informed by relatives that a person
had symptoms of schizophrenia or bipolar affective dis-
order. In these cases, a “best-guess” diagnosis according
to the RDC was entered into the database. In the case
of subjects who had been born and had died during the
19th century or who were estranged from their families,
we were reliant on family information and record books;
in many cases, no accurate information was available.
In these cases, subjects were recorded as being of either
unaffected or unknown affection status. Unless the
DSM-IIIR criteria for a possible schizotypal disorder
could be established on the basis of reliable information,
we did not record any individual as being affected. Ped-
igrees were selected on the basis of appearing to dem-
onstrate a single source of schizophrenia or DSM-IIIR
schizotypal illness, with unilineal transmission and no
cases of bipolar affective disorder. A pedigree was con-
sidered unilineal not just on the basis of the interview
diagnoses with the SADS-L but also on the basis of all
the information available to us from past records and
from relatives from the 1,850 individuals in the data-
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base. No families were excluded solely on the basis of
bilineal inheritance of schizotypal disorder, because in
all such families bilineality was also indicated by cases
of schizophrenia. Two affection classes were used for
the linkage analysis: “core schizophrenia” consists of
schizophrenia, unspecified functional psychosis, and
schizoaffective psychosis; “schizophrenia spectrum”
consists, in addition, of schizoid and schizotypal per-
sonality disorder, according to DSM-IIIR criteria. Of the
182 interviewed individuals in these 13 pedigrees, 56
were assigned to the core schizophrenia category and an
additional 12 were assigned to the spectrum category.
Fifty nanograms of total genomic DNA extracted from
venous blood samples was amplified by PCR with oli-
gonucleotide primers, according to the protocols of the
Ge´ne´thon linkage-mapping set (Gyapay et al. 1994). The
markers used were those identified by Ge´ne´thon and
were mapped to chromosomes in the CEPH families by
least-recombination methods, as described by Gyapay et
al (1994). Polyacrylamide gels were used to separate
amplified dinucleotide-repeat fragments, with either ra-
dioactive or fluorescent labeling. Genotypes were read
blind to diagnostic information. Tests for Mendelian in-
heritance of marker data were performed, and incon-
sistent genotypes were repeated or omitted.
Linkage analysis was performed by standard LOD-
score methods and using “model-free” likelihood-based
analysis. For LOD-score analyses, the VITESSE pro-
gram was used (O’Connell and Weeks 1995), except in
the case of markers on the X chromosome, for which
the FASTLINK program was used (Cottingham et al.
1993; Schaffer 1996). Separate analyses were performed
for the core and spectrum models, with penetrances of
.4 and .6 and phenocopy risks of .005 and .01, respec-
tively. Combined analyses were also performed using
liability classes, in which subjects falling into the dif-
ferent diagnostic categories were allocated the appro-
priate individual penetrance probabilities. For each of
the core, spectrum, and combined affection models,
analyses were performed under the assumption of either
dominant or recessive transmission, with the disease-
allele frequency set to .008 or .13, respectively. Thus,
each set of LOD-score analyses implemented six differ-
ent transmission models. For the initial screening anal-
yses, a set of two-point analyses was performed with
each marker, and a set of three-point analyses was per-
formed with each pair of adjacent markers. Overall
LOD scores were calculated under the assumption of
admixture, to produce an HLOD.
The “model-free” analyses were performed by the
MFLINK program (Curtis and Sham 1995 Curtis et al.
1999) and the accompanying MFMAP utility. With the
disease locus at a given map position, MFLINK cal-
culates the likelihood of the data, using a range of dif-
ferent dominant and recessive transmission models, all
yielding the same disease prevalence and parameterized
with a single variable, the heterozygote penetrance (f1,
which is varied from 0 to 1). The MLOD is the max-
imum LOD score obtained for any of these transmission
models (maximized over f1). The MALOD is the max-
imum admixture LOD obtained for any model (maxi-
mized over f1 and the proportion of families linked [a]).
TheMFLOD is the difference between the log likelihood
maximized over both f1 and a and the log likelihood
maximized over f1 but with a constrained to 0.MFLINK
analyses were performed with both the core and spec-
trum affection models, with the population prevalence
being set to .011 and .019 respectively, to match the
prevalences used for the LOD-score analyses. Two-point
analyses were performed with each marker, with the
tested position at a recombination fraction of .05 with
the marker, and three-point analyses were performed
with each pair of adjacent markers, testing a position
midway between them.
An initial screen of all the markers and pairs of mark-
ers was performed by the above methods. Each marker
and each pair of markers yielded six admixture LOD
scores and six LOD scores from the MFLINK analyses
(MLOD, MALOD, and MFLOD, for the core and spec-
trum models). Each type of LOD score was converted
to a likelihood-ratio statistic by multiplication by
. The statistic derived from the conven-2ln(10)p 4.6
tional admixture LOD score was taken to be distributed
as a 50:50 mixture of x22 and x
2
0. As originally described
(Curtis and Sham 1995), the likelihood-ratio statistic
from the MFLOD was taken to be distributed as a 50:
50 mixture of x21 and x
2
0. Subsequently (Curtis et al.
1999), it has been shown that can be2ln(10)#MLOD
taken to be distributed as x21 and that 2ln(10)#
can conservatively be taken to be distributedMALOD
as a 50:50 mixture of x22 and x
2
0. Using these distri-
butions allows P values to be derived so that the dif-
ferent types of LOD score can be compared more easily.
All regions that yielded a result significant at byP ! .01
any of the methods of analysis were selected for further
study.
Additional analyses from regions highlighted by the
screening analyses consisted of computation of over-
lapping five-point linkage scores, with sets of four ad-
jacent markers at a time. Regardless of which method
of analysis had produced the significant results, the five-
point analyses were performed for each of the six pos-
sible combinations of disease definition (core, spectrum,
or combined) and mode of transmission (dominant or
recessive).
Results
When all of the two-point and three-point HLODs and
MFLINK LOD scores were scrutinized, 16 regions con-
Table 1
Results Significant at , from Initial Screen of Two-Point and Three-Point Conventional and Model-Free Linkage AnalysesP ! .01
Marker at or near
Peak LOD Score
Map Position
(cM)
Cytogenetic
Location Most Significant Result Obtained Nominal P Comments on LOD Scores
D1S196 186.4 1q22.1-23 Core, recessive, three-point HLODp2.9 .0006 Nearby markers also positive
D2S125 267.0 2q23.3-24.2 Spectrum, two-point MLODp1.8 .004 Dominant HLODs positive
D3S1263 29.0 3p24.2-22 Spectrum, two-point MALODp1.8 .008
D3S1276 109.0 3p14.2-14.1 Core, three-point MLODp2.5 .0007 Dominant and recessive HLODs positive
D3S1262 107.2 3q27 Spectrum, three-point MFLODp1.3 .007 Dominant HLODs positive
D4S418 43.9 4q13-31 Spectrum, three-point MFLODp1.5 .004 Dominant and recessive HLODs positive
D4S430 125.1 4q13-31 Spectrum, two-point MFLODp2.4 .0004 Dominant and recessive HLODs positive, nearby markers positive
D5S407 65.0 5p14.1-13.1 Spectrum, dominant, two-point HLODp2.5 .002
D5S422 163.9 5q32-33 Spectrum, dominant, three-point HLODp3.6 .0001 Nearby markers positive
D7S691 64.6 7p13 Core MLODp1.4 .01
D8S503 16.2 8p22 Core, recessive, two-point HLODp3.6 .0001 8p markers positive over wide region
D8S503, D8S504 16.2 8p22 Core, three-point HLODp3.5 .0001 Recessive HLODs strongly positive, dominant ones less so
D11S922 3.9 11p11.5 Spectrum, three-point MLODp1.6 .007 Recessive HLODs positive
D11S934 132.9 11q23.3-24 Spectrum, recessive, two-point HLODp3.1 .0004 Nearby markers positive
D12S43 81.5 12q12-24.1 Core, three-point MALODp2.0 .005 Dominant HLODs positive
D19S220 61.4 19q13.1 Spectrum, two-point MLODp1.5 .009
D20S112 39.3 20q12.1-11.23 Spectrum, recessive, three-point HLODp2.4 .002 Nearby markers positive
D21S1256 8.7 21q11.1-21.1 Spectrum, two-point MALODp1.9 .006 Dominant and recessive HLODs positive
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taining the following markers produced at least one sta-
tistic that was nominally significant at : D1S194-P ! .01
D1S196-D1S2815, D2S125, D3S1263, D3S1261-
D3S1276, D4S411-D4S406-D4S430, D5S426-D5S407-
D5S2306, D5S410-D5S422-D5S400, D8S504-D8S503-
D8S552-D8S261-D8S258-D8S1771-D8S283-D8S285,
D8S286-D8S273, D11S922, D11S925-D11S934-
D11S4150, D12S85, D12S43-D12S92, D19S220,
D20S186-D20S112, and D21S1911-D21S1256. Those
markers with the most-positive results in these regions are
detailed in table 1. In several of these regions, more than
one marker and/or method of analysis yielded positive
LOD scores. Figure 1 shows the three-point MALOD
scores for the core and spectrum affection models, as well
as the three-point HLODs for the combined affection
model, under assumptions of dominant and recessive
transmission. The full set of results is available from
D.C.’s Web site (“Results of genome scan for schizo-
phrenia”). The regions highlighted by the two-point and
three-point screening analyses were investigated more in-
tensively by overlapping five-point analyses, and the re-
sults are presented in table 2. For some of the regions,
evidence for linkage is maintained or enhanced, whereas
for others the five-point LOD-score analyses do not sup-
port linkage. Admixture LOD scores 3.0 were found
for the regions D1S194-D1S196-D1S2815-D1S191-
D1S412, D5S410-D5S422-D5S400-D5S2111, D8S504-
D8S503-D8S552-D8S261-D8S1771, and D11S898-
D11S35-D11S925-D11S934-D11S4150. Only one Ice-
landic pedigree, family 4, individually produces a LOD
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Figure 1 Graphs of three-point LOD scores for schizophrenia against map position (cM), for MALODs with different definitions of
affection and for HLODs, under assumptions of dominant and recessive transmission. Blackened diamonds () p MALOD, core affection
model; unblackened squares () p MALOD, combined (core and spectrum) affection model; solid line (——) p HLOD, combined (core and
spectrum) affection model, dominant transmission; dashed line (- - - -) p HLOD, combined (core and spectrum) affection model, recessive
transmission.
score 3.0, and it does so for three different regions
near D4S411-D4S406-D4S430-D4S422, D11S934, and
D20S112. The five-point LOD scores in individual ped-
igrees were examined carefully. Results of this procedure
are noted in table 2. By and large, specific families tended
to show positive LOD scores for certain loci while show-
ing negative LOD scores in other regions; the exception
was family 4, which simultaneously produced LOD
scores 13.0 at D4S430, D11S934, and D20S112. These
data have not been published before and are part of a
wider unpublished collaborative linkage study of schizo-
phrenia, organized by the ESF.
Discussion
The optimal method for analysis of linkage data for a
disease with complex inheritance remains uncertain. We
have chosen to apply a range of LOD-score analyses
that use different disease definitions and either recessive
or dominant transmission, along with model-free like-
lihood-based analyses, all applied, in the first instance,
to both two-point and three-point data, which resulted
in a substantial number of partially independent results.
We did not apply nonparametric sib-pair linkage anal-
ysis or the methods implemented in GENEHUNTER
Table 2
Results of Five-Point LOD-Score Analysis of Regions Highlighted by Initial Screening Analyses
Marker at
or near Peak
LOD Score
Map Position
(cM)
Cytogenetic
Location
Peak
HLOD Model Used Nominal Pa Comments on LOD Scores
D1S196 186.4 1q33.2 3.2 Core, recessive .0003 Homogeneity LOD score 2.8; LOD score 1 1 in pedigrees 1, 2 and 3
D2S125 267.0 2q23.3-24.2 1.8 Spectrum, recessive .008 LOD score 1.2 in pedigree 4
D3S1277 56.1 3p24.2-22 .8 Combined, recessive .07 LOD score 1 1 in pedigrees 3 and 5
D3S1285 91.0 3p14.2-14.1 1.0 Core, recessive .05 LOD score 1 .7 in pedigrees 3, 4, 11; LOD score 1.2 in pedigree 2, using dominant models
D3S1262 107.2 3q27 1.5 Combined, dominant .02 LOD score 2.2 in pedigree 6
D4S418 43.9 4q13-31 1.8 Combined, recessive .007 LOD score 1 .7 in pedigrees 1, 2, 7, 8, 9
D4S411 107.4 4q13-31 2.1 Core, recessive .004 LOD score 1 .7 in pedigree 3, 4, 6, 10
D4S430 125.1 4q13-31 2.0 Combined, dominant .005 LOD score 3.2 in pedigree 4
D5S426 51.6 5p14.1-13.1 2.2 Combined, dominant .003 LOD score 2.3 in pedigree 6; LOD score 1.2 in pedigree 3
D5S422 163.9 5q32-33 2.8 Spectrum, dominant .0008 LOD score 2.5 in pedigree 6; LOD score 1.5 in pedigree 3
D7S691 64.6 7p13 .3 Core, dominant NS No support for linkage from five-point analyses
D8S503 16.2 8p21-22 2.8 Core, recessive .0008 Homogeneity LOD score 2.7; LOD score 1.1 in pedigree 10; otherwise, several small LOD scores
D8S1771 50.3 8p21-22 3.2 Core, recessive .0005 Homogeneity LOD score is also 3.0; LOD score 1.7 in pedigree 6; LOD score .97 in pedigree
10; otherwise, several small LOD scores; positive LOD scores over large region of 8p
D11S922 3.9 11p11.5 .5 Core, recessive NS No support for linkage from five-point analyses
D11S934 132.9 11q23.3-24 2.9 Combined, recessive .0006 LOD score 3.2 in pedigree 4; LOD score 1.0 in pedigree 5
D12S43 81.5 12q12-24.1 0 NS No support for linkage from five-point analyses
D19S220 61.4 19q13.1 .4 Spectrum, dominant NS No support for linkage from five-point analyses
D20S112 39.3 20q12.1-11.23 2.4 Spectrum, recessive .002 LOD score 2.9 in pedigree 4; 1.2 in pedigree 7
D21S1256 8.7 21q11.1-21.1 1.7 Spectrum, dominant .01 LOD score 2.4 in pedigree 1
NOTE.—The highest admixture LOD score obtained from any of the six models tested (for each of the possible combinations of disease definition [core or combined {core and spectrum}]
and mode of transmission [dominant or recessive]) is shown, together with information regarding the model that produces this score and the pedigree(s) that appears to make the main
contribution to it.
a NS p not significant.
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(Kruglyak et al. 1996), because such analyses can lose
much of the genetic information provided by large mul-
tiply affected pedigrees. Each method of analysis that
we have used generates a statistic, which can be com-
pared with a standard distribution, to obtain a corre-
sponding P value. To obtain an overall significance for
each result, one would need to be able to correct for the
following facts: (a) several prior linkage studies of these
loci have been performed, (b) our own data consist of
several partially independent analyses performed at each
map position, and (c) multiple partially independent
markers are tested. Although, theoretically, one can ob-
tain a genomewide significance if only one method of
analysis is applied at each position (Lander and Krug-
lyak 1995), such a correction is impractical when mul-
tiple methods or two-point, rather thanmultipoint, anal-
yses are performed (Curtis et al. 1995). We therefore
provide the LOD scores with their corresponding un-
corrected nominal P values. It should be noted that
the MFLINK analyses do not maximize the likelihood
over the recombination fraction but use a single genetic
distance; thus, no extra degree of freedom is introduced
in this approach, compared with traditional LOD-score
analyses, at a fixed set of penetrances. Since similar con-
siderations apply to most, if not all, previous linkage
studies of schizophrenia, the uncorrected P values we
provide at least allow some comparison with other
studies.
As described in the abstract, several positive regions
were identified by the initial two-point and three-point
analyses; however, we regard the five-point analyses as
providing the most robust evidence for linkage. When
two-point linkage analyses are performed, there may be
large differences between the results obtained from ad-
jacent markers, owing to random variation in the sub-
set of meioses for which each marker is informative. By
contrast, multipoint analysis can provide almost com-
plete information regarding the inheritance of each
chromosomal segment and should be far less sensitive
to this random noise. A disadvantage of multipoint
analysis may be that model misspecifications are more
likely to produce incorrect results—especially, spurious
exclusions (Morton 1988; Risch and Giuffra 1992).
However, such concerns may be exaggerated (Green-
berg et al. 1998), and our own results certainly include
a number of strongly positive LOD scores. We have also
examined the LOD scores of individual pedigrees in the
context of the genome scan, and doing so has illumi-
nated the complex implications of some of our results.
Amongst the regions highlighted by positive LOD scores
in our initial analyses, two five-point analyses produce
overall admixture LOD scores 13.0 and two others pro-
duce LOD scores 13.0 in a single pedigree. A number
of other regions apparently implicated in the initial two-
point scan produce, in five-point analyses, either neg-
ligible support for linkage or intermediate results.
The most-promising results obtained are for the
1q32.2, 8p21-22, 11q21, and 5q33.2 regions. The
8p21-22 markers yield a maximum two-point LOD
score of 3.6, a three-point LOD score of 3.52, and a
five-point LOD score of 3.2, with other markedly pos-
itive LOD scores extending over a wide region. We be-
lieve that, if these results are considered together with
the three other prior independent LOD scores 13.0 for
8p21-22 that have been reported by other research
groups, there is now very good evidence for a schizo-
phrenia-susceptibility locus in this region. Although our
method for selection of pedigrees might have been ex-
pected to enrich the sample for dominant genes, the
evidence for linkage, in fact, arises mostly through use
of a recessive model. In addition, we find no statistically
significant evidence for admixture. However, these am-
biguities may be artifacts due to lack of informativeness
of certain markers in certain subjects and kindreds. The
peaks at D8S503 and D8S1771, which are 30 cM apart,
are not clearly distinct from one another and the LOD
score between them is not much lower than those at
the peaks. We therefore cannot draw from these data
any definite conclusions about the precise localization
of susceptibility mutations.
The highest overall five-point admixture LOD score
(3.2) is obtained in the region around D1S196, again
by a recessive model. Under the assumption of homo-
geneity, the LOD score is 2.8. As described above, in-
dependent samples have also provided strong support
for linkage to this region, with LOD scores of 3.82 and
6.50 (Hovatta et al. 1999; Brzustowicz et al. 2000). We
therefore conclude that, overall, there is also very good
evidence for the presence, within this region, of a schizo-
phrenia-susceptibility locus.
Two five-point LOD scores of 3.2 are produced
within a single family, near the loci D4S430 and
D11S934; the first occurs with a dominant model, the
second with a recessive one. It is possible that a 4q31
dominant gene and an 11q recessive gene exert a com-
bined effect to produce disease in this family or that
one of the LOD scores is a false positive. Support for
linkage at the same 4q31 region has been described in
a Finnish study (Hovatta et al. 1999), with a LOD score
of 2.74 with marker D4S1586. The overall maximum
admixture LOD score at D11S934 is 3.2, and, as has
been described above, other researchers have obtained,
from other samples, independent support for linkage to
this region. The cytogenetic abnormality cosegregating
with schizophrenia in a Scottish family (St. Clair et al.
1990) might be interpreted as being a linkage marker
for schizophrenia, rather than being a direct etiological
factor causing disruption of a susceptibility gene. If this
were the case, then our positive results with 11qmarkers
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would confirm this linkage and that reported by Ma-
ziade et al. (1995). Interestingly, the same pedigree that
produces LOD scores of 3.2 in these two regions also
produces a five-point LOD score of 2.9 near D20S112.
Once again, this may represent an interactive effect or
a situation in which one or more results have occurred
by chance.
The other results of note are the admixture LOD
scores obtained using dominant-transmission models
with markers at 5p14.1-13.1 (two-point LOD score 2.5,
three-point LOD score 2.5, and five-point LOD score
2.2) and at 5q32-33 (three-point LOD score 3.6 and
five-point LOD score 2.8). The results for the 5p14.1-
13.1 markers reflect the schizophrenia linkage that we
reported with D5S76 (Sherrington et al. 1988), which
is now mapped to this region. This finding supports
both that by Silverman et al. (1996), who reported a
LOD score of 4.4, and that by Garver et al. (1998),
who reported a LOD score of 2.5, both in the same
region. On the long arm of chromosome 5, positive
LOD scores obtained with 5q32-33 markers replicate
the findings by Straub et al. (1997b), Byerley et al.
(1999), and Paunio et al. (2000), who have all reported
LOD scores 13 with markers in this region. Our ped-
igrees failed to show any suggestion of linkage to a
number of regions implicated by other researchers on
chromosome 6p22-24 (SCZD3 [MIM 600511]) (An-
tonarakis et al. 1995; Gurling et al. 1995; Moises et al.
1995; Schwab et al. 1995; Straub et al. 1995; Wang et
al. 1996; Brzustowicz et al. 1997; Maziade et al. 1997;
Turecki et al. 1997; Levinson et al. 2000), chromosome
6q21-q22.3 (SCZD5 [MIM 603175]) (Cao et al. 1997;
Kaufmann et al. 1998), chromosome 7 (Ekelund et al.
1999), chromosome 10 (Faraone et al. 1998; Levinson
et al. 1998; Schwab et al. 1998; Straub et al. 1998),
chromosome 13 (Lin et al. 1995, 1997; Straub et al.
1997a; Blouin et al. 1998; Shaw et al. 1998; Brzusto-
wicz et al. 1999), and chromosome 22 (SCZD4 [MIM
600850]) (Kalsi et al. 1995a). These loci are unlikely
to have had a major effect on a substantial proportion
of the pedigrees considered in the present study. It is
possible that the strict selection criteria that we adopted,
in which families were rejected if they contained cases
of both schizophrenia and bipolar affective disorder,
may have biased our positive findings away from de-
tection of linkage on chromosomes 6p and 13q. On the
other hand, those families that we rejected because they
contained cases of both schizophrenia and bipolar af-
fective disorder clearly had bilineal descent for each type
of disorder within a kindred. Such an observation is
inconsistent with the idea that these two disorders share
any common genetic etiology.
It has become clear that, for a disease with complex
inheritance such as schizophrenia, linkage analysis can
produce limited inferences as to the nature and locali-
zation of any genes that might be exerting an effect on
susceptibility. More-definitive results will require a con-
sideration of linkage-study results combined from dif-
ferent data sets, as well as a consideration of evidence
for linkage disequilibrium. For now, we conclude that
there is strong support, from multiple studies, for schizo-
phrenia-susceptibility loci on 1q33.2, 8p21-22, and
5q32-33. More specifically, we believe that these loci are
very unlikely to have been falsely implicated, as a result
of multiple testing, in previous and present linkage stud-
ies. Further less-well-confirmed linkage evidence also ex-
ists for susceptibility loci on 4q13-31, 5p14.1-13.1,
6p24-22, 10p12-13, 11q23.3-24, 20q12.1-11.23, and
22q21. We expect that other, less common susceptibility
genes exist and that further linkage analyses will even-
tually confirm their presence.
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